Use the following year-end footnote disclosure from Pfizer‘s 10-K report to answer the following question.
(Millions of Dollars) 2005
Cost of available for sale equity securities $270
Gross unrealized gains 189
Gross unrealized losses (12)
Fair value of available for sale equity securities $447
What amount does Pfizer report on its 2005 balance sheet as available-for-sale equity securities?
A. $270 millionB. $447 millionC. $459 millionD. $258 million